612.19
+3.7575(+0.62%)
Currency In USD
Address
5375 Medpace Way
Cincinnati, OH 45227
United States of America
Phone
513 579 9911
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
5900
First IPO Date
August 11, 2016
| Name | Title | Pay | Year Born |
| August James Troendle | Chairman & Chief Executive Officer | 1.53M | 1956 |
| Kevin Brady | Chief Financial Officer & Treasurer | 656,750 | 1974 |
| Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary | 871,950 | 1969 |
| Jesse J. Geiger | President | 939,067 | 1974 |
| Susan E. Burwig | Executive Vice President of Operations | 1.06M | 1963 |
| Brandon Ebken | Chief Information Officer | 0 | N/A |
| John T. Wynne | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | 0 | N/A |
| Todd Meyers | Vice President of Business Development & Marketing | 0 | N/A |
| Weimin Gai | Senior Vice President of Biometrics | 0 | N/A |
| Lauren Morris | Associate Director of Investors Relations | 0 | N/A |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.